一分钟看懂
这是一项关于结直肠癌的I 期研究,登记的药物或干预包括iNeo-Vac-T01,当前状态为招募中。登记地点显示中国杭州有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。
药物或干预
iNeo-Vac-T01 · I 期
登记条件中文摘要
年龄范围:18岁至70岁
登记的基本范围为不限性别,年龄18岁至70岁;以下仅摘录8项专业入选条件,需结合英文原文并由研究团队确认。
登记记录列出8项主要排除条件,具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息,不代表此刻仍有名额;请向研究中心确认最新情况。
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China · 杭州
入选条件原文摘录
以下为摘录,请打开原始登记查看完整入排标准。
- 1. Aged ≥ 18 years and ≤ 70 years;
- 2. Patients with pathologically and radiologically confirmed advanced colorectal cancer, with at least one measurable lesion on imaging;
- 3. Failure of standard therapy, ineligibility for standard therapy, or refusal to receive standard therapy;
- 4. Expected survival of at least 6 months;
- 5. Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1;
- 6. Sufficient tumor tissue sample available for genomic analysis, or existing whole-genome/whole-exome/transcriptome sequencing data of tumor and normal tissues that meet analytical requirements;
- 7. Normal function of major organs including heart, liver, and kidney;
- 8. Normal hematological parameters:
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号:NCT07504523;登记信息更新于 2026-04-01;本站同步于 2026-11-21。